ANDA 77930, held by Impax Labs Inc. Meloxicam.
As of Nov 14, 2026, ANDA 77930 (Meloxicam), held by Impax Labs Inc, was first approved by FDA on Jul 19, 2006, with 1 approved supplement and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 19, 2006 | Original application | Approved |
| Nov 5, 2007 | Supplement 1Labeling | Approved | None posted |
| Jul 19, 2006 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters